Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Avatar Builder  |  Contact Info  |  Update Email  |  Update Password  |  Leaderboards  |  Manage Favourite  |  Reputation  |  Reputation History  |  Subscriptions  |  Payment Info  |  Invoices  |  Favourites

Bullboard Post History

by Management1st

T.OSK

RE:RE:RE:RE:RE:RE:RE:I Don't Like The GFI Deal

The stock will stay under pressure as long as management keeps going on with...

May 10, 2023

T.OSK

RE:Something up

Just catching up from where it left before the private placement..

March 22, 2023

T.OSK

RE:OSK 'updated' FS. Missed the biggest update.

I second this opinion

January 12, 2023

T.OSK

RE:RE:RE:RE:Golden Cross for OSK

Technicaly speaking this is still in the lower range of the uptrend and this...

January 12, 2023

T.OSK

RE:Feasibility can't come fast enough...

this week increase as all to do with the POG... nothing to do with the coming...

November 11, 2022

T.OSK

RE:RE:RE:RE:RE:Eight Capital target $8.00 and others $4.50 to $6.50

All in all the improvement with the resources, the POG and the average grade...

November 8, 2022

T.OSK

RE:RE:RE:Eight Capital target $8.00 and others $4.50 to $6.50

time will tell

November 7, 2022

T.OSK

RE:Eight Capital target $8.00 and others $4.50 to $6.50

FS will show the real value

November 6, 2022

T.OSK

RE:a problem with the volume this morning

my biggest wish is to get an email saying that OSK is halted... we all would...

November 1, 2022

T.OSK

RE:RE:RE:RE:Osisko buying back shares ,1 million in May and

the same for the powerline agreement it was due H1 2022

June 21, 2022

T.OSK

RE:RE:Osisko buying back shares ,1 million in May and

Before the buyback program, OSK had 359M shares, they since bought back...

June 21, 2022

T.OSK

RE:The 'Disagreement'

Egos!

February 17, 2022

T.OSK

RE:RE:RE:RE:Just remember

I hope they are all employedm = still gaining experience. Nobody want the guy...

February 17, 2022

T.OSK

RE:RE:RE:RE:Just remember

It's a leap of faith of Kinross and no other majors fought for it either!...

February 17, 2022

T.OSK

RE:RE:Just remember

I agree with your point but back then they did not had the experience of open...

February 17, 2022

T.OSK

RE:RE:RE:RE:Northern Star - Negotiations concluded with Osisko Mining

Just to put things into perspective GBR was bought for $1.8B without an MRE.....

February 17, 2022

T.OSK

Just remember

OSK1 did it alone and sold for $3.9B. Why wouldn't they be able to repeat...

February 17, 2022

T.OSK

RE:RE:Northern Star - Negotiations concluded with Osisko Mining

Great news! The 2 best possible scenarios are (not necessarily in order...

February 17, 2022

GTBDF

RE:RE:MRE

That was also my feeling! Nobody fought for this project, it's certainly...

February 16, 2022

GTBDF

RE:MRE

that will be helpful to benchmark OSK ;)

February 16, 2022

1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 ... Next

Featured Company

Revive Therapeutics Ltd.

Revive Therapeutics Ltd. C.RVV

Revive Therapeutics Ltd. is a Canada-based life sciences company. The Company is focused on the research and development of ... view more »